Elizabeth Reed

Elizabeth Reed serves as senior vice president, general counsel, and corporate secretary of Travere Therapeutics. She has been with the company since January 2017 and is responsible for overseeing the company’s generally legal, intellectual property, government affairs, and corporate compliance functions.

Previously, Ms. Reed served as general counsel of Celladon Corporation, and prior to Celladon, served as general counsel of Anadys Pharmaceuticals, Inc. until Anadys’ acquisition by Roche. Prior to joining Anadys, she was an attorney with the law firms Cooley Godward LLP and Brobeck, Phleger & Harrison LLP. Ms. Reed is a member of the State Bar of California and received her law degree from Harvard Law School and her bachelor’s in business administration from the University of California at Berkeley.